[1]
Dr. Rajesh Ponugupati, “EFFICACY AND SAFETY OF DUAL INTERLEUKIN-17A AND INTERLEUKIN-17F INHIBITION WITH BIMEKIZUMAB IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 RANDOMISED CONTROLLED TRIAL”, J Popl Ther Clin Pharmacol, vol. 23, no. 2, pp. 237–246, May 2016, doi: 10.53555/am143177.